Welcome news for dogs and their owners

MMVD is the most common type of heart disease in dogs. It is a slowly progressive condition that can eventually lead to CHF.

The EPIC Study offers encouraging findings to pet owners whose dogs have preclinical MMVD. EPIC showed that administration of pimobendan to preclinical dogs was found to significantly extend the symptom-free period of those dogs’ lives by an average of 15 months.¹